sparfloxacin has been researched along with Pulmonary Consumption in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaiprasert, A; Disratthakit, A; Doi, N; Leechawengwongs, M; Prammananan, T; Thaipisuttikul, I; Tribuddharat, C | 1 |
| Khaĭmenov, AIa; Khaĭmenova, TIu; Lazareva, IaV; Sokolova, GB | 1 |
| Byotra, SP; Kakar, A | 1 |
| Ahluwalia, G | 1 |
| Rao, S | 1 |
| Mahajan, VK; Sharma, NL | 1 |
| Squire, SB; Vizel, AA; Ziganshina, LE | 1 |
| Biron, MG; Bogadel'nikova, IV; Borisov, SE; Khaĭmenova, TIa; Lazareva, IaV; Mozhokina, GN; Sokolova, GB; Tsibanev, AA | 1 |
| Cynamon, MH; Klemens, SP; Rogge, MC; Sharpe, CA | 1 |
| Grosset, J; Ji, B; Lalande, V; Paccaly-Moulin, A; Truffot-Pernot, C | 1 |
| Adam, G; Haase, G; Riehl, J; Schmitt, H; Schnitzler, N; Sieberth, HG | 1 |
| Erbes, R; Lode, H; Lubasch, A; Mauch, H | 1 |
| Arora, VK; Gupta, R; Gupta, S; Singla, R | 1 |
| Nagatake, T; Oishi, K; Satoh, S; Watanabe, K | 1 |
| Kamisaka, K; Kawahara, S; Kibata, M; Konishi, H; Matsuyama, T; Mishima, Y; Shiomi, K; Tada, A; Takeuchi, M; Yoshimoto, S | 1 |
1 review(s) available for sparfloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
Fluoroquinolones for treating tuberculosis.
Topics: Antitubercular Agents; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Ofloxacin; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2005 |
3 trial(s) available for sparfloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
[Sparfloxacin in combined therapy for pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Arrhythmias, Cardiac; Dermatitis, Phototoxic; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium tuberculosis; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2008 |
[The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis].
Topics: Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2007 |
Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Culture Media; Dermatitis, Phototoxic; Drug Therapy, Combination; Ethionamide; Fluoroquinolones; Humans; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Prospective Studies; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
11 other study(ies) available for sparfloxacin and Pulmonary Consumption
| Article | Year |
|---|---|
Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Topics: Aminopyridines; Antitubercular Agents; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Gene Expression; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Thailand; Tuberculosis, Pulmonary | 2016 |
Torsade de pointes probably induced by sparfloxacin.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Torsades de Pointes; Tuberculosis, Pulmonary | 2002 |
Torsade de pointes probably induced by sparfloxain.
Topics: Adult; Diagnosis, Differential; Female; Fluoroquinolones; Humans; India; Long QT Syndrome; Torsades de Pointes; Tuberculosis, Pulmonary | 2003 |
Uncontrolled trial of sparfloxacin in retreatment of pulmonary tuberculosis.
Topics: Adult; Antitubercular Agents; Female; Fluoroquinolones; Humans; Male; Middle Aged; Retreatment; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Photo-onycholysis due to sparfloxacin.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Fluoroquinolones; Humans; Male; Nails; Photosensitivity Disorders; Tuberculosis, Pulmonary | 2005 |
Activity of levofloxacin in a murine model of tuberculosis.
Topics: Animals; Antitubercular Agents; Culture Media; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoroquinolones; Levofloxacin; Lung; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Quinolones; Spleen; Stereoisomerism; Tuberculosis, Pulmonary | 1994 |
Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.
Topics: Animals; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Lung; Mice; Mycobacterium tuberculosis; Quinolones; Spleen; Tuberculosis, Pulmonary | 1993 |
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Killer Cells, Natural; Lung; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifabutin; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antitubercular Agents; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2001 |
[A case report of pulmonary nocardiosis associated with bronchiectasis after pulmonary tuberculosis successfully treated with sparfloxacin].
Topics: Anti-Infective Agents; Antitubercular Agents; Bronchiectasis; Female; Fluoroquinolones; Humans; Lung Diseases; Middle Aged; Nocardia asteroides; Nocardia Infections; Tuberculosis, Pulmonary | 2002 |
[A case of pulmonary atypical mycobacteriosis complicated with aplastic anemia, treated with surgical resection and postoperative sparfloxacin].
Topics: Anemia, Aplastic; Anti-Infective Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Quinolones; Tuberculosis, Pulmonary | 1992 |